These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. Pasternak B; Svanström H; Mølgaard-Nielsen D; Krause TG; Emborg HD; Melbye M; Hviid A JAMA; 2012 Jul; 308(2):165-74. PubMed ID: 22782418 [TBL] [Abstract][Full Text] [Related]
3. Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants. Chambers CD; Johnson D; Xu R; Luo Y; Jones KL; Birth Defects Res; 2019 Nov; 111(19):1487-1493. PubMed ID: 31397112 [TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study. Dunstan HJ; Mill AC; Stephens S; Yates LM; Thomas SH BJOG; 2014 Jun; 121(7):901-6. PubMed ID: 24602087 [TBL] [Abstract][Full Text] [Related]
5. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data. Donner B; Niranjan V; Hoffmann G Drug Saf; 2010 Aug; 33(8):631-42. PubMed ID: 20635821 [TBL] [Abstract][Full Text] [Related]
6. Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic. Xie HY; Yasseen AS; Xie RH; Fell DB; Sprague AE; Liu N; Smith GN; Walker MC; Wen SW Am J Obstet Gynecol; 2013 Apr; 208(4):293.e1-7. PubMed ID: 23333544 [TBL] [Abstract][Full Text] [Related]
7. Oseltamivir exposure in pregnancy and the risk of specific birth defects. Van Bennekom CM; Kerr SM; Mitchell AA Birth Defects Res; 2019 Nov; 111(19):1479-1486. PubMed ID: 31397115 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Pregnancies for Women Undergoing Endoscopy While They Were Pregnant: A Nationwide Cohort Study. Ludvigsson JF; Lebwohl B; Ekbom A; Kiran RP; Green PH; Höijer J; Stephansson O Gastroenterology; 2017 Feb; 152(3):554-563.e9. PubMed ID: 27773807 [TBL] [Abstract][Full Text] [Related]
9. Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy. Svensson T; Granath F; Stephansson O; Kieler H Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1030-4. PubMed ID: 21774030 [TBL] [Abstract][Full Text] [Related]
10. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: exposure prevalence, preterm delivery, and specific birth defects. Louik C; Ahrens K; Kerr S; Pyo J; Chambers C; Jones KL; Schatz M; Mitchell AA Vaccine; 2013 Oct; 31(44):5033-40. PubMed ID: 24016804 [TBL] [Abstract][Full Text] [Related]
11. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106 [No Abstract] [Full Text] [Related]
12. The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Cunnington M; Ephross S; Churchill P Headache; 2009; 49(10):1414-22. PubMed ID: 19804390 [TBL] [Abstract][Full Text] [Related]
13. The Relationship Between 2009 Pandemic H1N1 Influenza During Pregnancy and Preterm Birth: A Population-based Cohort Study. Fell DB; Platt RW; Basso O; Wilson K; Kaufman JS; Buckeridge DL; Kwong JC Epidemiology; 2018 Jan; 29(1):107-116. PubMed ID: 28930786 [TBL] [Abstract][Full Text] [Related]
14. The safety of oseltamivir in pregnancy: an updated review of post-marketing data. Wollenhaupt M; Chandrasekaran A; Tomianovic D Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1035-42. PubMed ID: 24995623 [TBL] [Abstract][Full Text] [Related]
15. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry. Vannappagari V; Albano JD; Koram N; Tilson H; Scheuerle AE; Napier MD Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():6-10. PubMed ID: 26687320 [TBL] [Abstract][Full Text] [Related]
16. Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database. Beau AB; Hurault-Delarue C; Vial T; Montastruc JL; Damase-Michel C; Lacroix I BJOG; 2014 Jun; 121(7):895-900. PubMed ID: 24512604 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir. Vannappagari V; Thorne C; J Acquir Immune Defic Syndr; 2019 Aug; 81(4):371-378. PubMed ID: 30939532 [TBL] [Abstract][Full Text] [Related]
18. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Chambers CD; Johnson D; Xu R; Luo Y; Louik C; Mitchell AA; Schatz M; Jones KL; Vaccine; 2013 Oct; 31(44):5026-32. PubMed ID: 24016809 [TBL] [Abstract][Full Text] [Related]
19. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development. Larsen AD Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513 [TBL] [Abstract][Full Text] [Related]
20. Neonatal outcomes in women with Multiple Sclerosis - Influence of disease activity: A Danish nationwide cohort study. Andersen ML; Jølving LR; Iachina M; Anru PL; Stenager E; Knudsen T; Nørgård BM Mult Scler Relat Disord; 2024 May; 85():105549. PubMed ID: 38518505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]